← Leaderboards
Stephen Gerard Kaler
Children'S Hosp Of Philadelphia
$4,373,795
Attributed
$4,926,885
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,926,885 · 2
By mechanism
U01$4,926,885 · 2
Top collaborators
- John H Wolfe2 shared
Others in their field
Top investigators on “Preclinical Study”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$269,140,071
- David Heimbrook · Leidos Biomedical Research, Inc.$106,323,837
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$78,114,132
- Reisa A. Sperling · Banner Health$77,026,005
- Randall J Bateman · Washington University$68,100,867
Research focus
Preclinical StudyRecombinantsGenesMenkes Kinky Hair SyndromeNatural HistoryPre-ClinicalClinical TrialsFutureInnovationMediatingMouse ModelBiochemicalNeurologicPilot ProjectsBiological ProductsAffectCopperDoseGene TherapyHuman SubjectInterestLaboratoriesAnimalsSafety
Grant awards (5)
Viral Gene Therapy for Menkes Disease$2,522,499
U01 · FY2025 · NS · contact PI
Viral Gene Therapy for Menkes Disease$922,463
U01 · FY2023 · NS · contact PI
Viral Gene Therapy for Menkes Disease$375,742
U01 · FY2023 · NS · contact PI
Choroid Plexus-Directed Gene Therapy for Alpha-Mannosidosis$530,182
U01 · FY2017 · HD
Choroid Plexus-Directed Gene Therapy for Alpha-Mannosidosis$575,999
U01 · FY2016 · HD